Cargando…

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer

BACKGROUND: Local‐regional failure (LF) for locally advanced bladder cancer (LABC) after radical cystectomy (RC) is common even with chemotherapy and is associated with high morbidity/mortality. Postoperative radiotherapy (PORT) can reduce LF and may enhance overall survival (OS) but has no defined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer‐Valuck, Benjamin W., Michalski, Jeff M., Mitra, Nandita, Christodouleas, John P., DeWees, Todd A., Kim, Eric, Smith, Zachary L., Andriole, Gerald L., Arora, Vivek, Bullock, Arnold, Carmona, Ruben, Figenshau, Robert S., Grubb, Robert L., Guzzo, Thomas J., Knoche, Eric M., Malkowicz, S. Bruce, Mamtani, Ronac, Pachynski, Russell K., Roth, Bruce J., Zaghloul, Mohamed S., Gay, Hiram A., Baumann, Brian C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639450/ https://www.ncbi.nlm.nih.gov/pubmed/31119885 http://dx.doi.org/10.1002/cam4.2102

Ejemplares similares

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2018)

Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
por: Narayan, Vivek, et al.
Publicado: (2016)

Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2021)

Radiomics-guided therapy for bladder cancer: Using an optimal biomarker approach to determine extent of bladder cancer invasion from t2-weighted magnetic resonance images
por: Tong, Yubing, et al.
Publicado: (2018)

Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
por: Roy, Amit, et al.
Publicado: (2021)

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019)

Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018
por: Parikh, Ravi B., et al.
Publicado: (2020)

Association between hospital competition and quality of prostate cancer care
por: Jayadevappa, Ravishankar, et al.
Publicado: (2023)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

Umbilical sparing robotic partial cystectomy for localized urachal adenocarcinoma: A case report
por: Connor, Jessica, et al.
Publicado: (2021)

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
por: Bansal, Dhruv, et al.
Publicado: (2021)

Tumor Enucleation for Renal Cell Carcinoma
por: Smith, Zachary L., et al.
Publicado: (2015)

Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer
por: Jayadevappa, Ravishankar, et al.
Publicado: (2019)

Continuity of care and advanced prostate cancer
por: Jayadevappa, Ravishankar, et al.
Publicado: (2023)

Panniculectomy and Cystectomy: An Approach to the Morbidly Obese Patient
por: Hugar, Lee A., et al.
Publicado: (2016)

The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
por: Waters, Michael R, et al.
Publicado: (2023)

Outcome for Children with Metastatic Solid Tumors over the Last Four Decades
por: Perkins, Stephanie M., et al.
Publicado: (2014)

Prospective Randomized Comparison of Cutting and Dilating Disposable Trocars for Access During Laparoscopic Renal Surgery
por: Venkatesh, Ramakrishna, et al.
Publicado: (2007)

Magnetic Resonance Image Guided Stereotactic Body Radiation Therapy to the Primary Renal Mass in Metastatic Renal Cell Carcinoma
por: Rudra, Soumon, et al.
Publicado: (2019)

Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience
por: Cosper, Pippa F., et al.
Publicado: (2017)

Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations
por: Hannan, Zain, et al.
Publicado: (2021)

Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020)

Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does total dose matter?
por: Germino, Elizabeth, et al.
Publicado: (2018)

Telehealth: An Effective Model of Care for Renal Cancer Surveillance
por: Caruso, Adele Marie, et al.
Publicado: (2022)

Physical Activity and Benign Prostatic Hyperplasia-Related Outcomes and Nocturia
por: WOLIN, KATHLEEN Y., et al.
Publicado: (2015)

Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone
por: Marar, Mallika, et al.
Publicado: (2022)

Diminished Short-Term Efficacy of Reduced-Dose Induction BCG in the Treatment of Non-Muscle Invasive Bladder Cancer
por: Ostrowski, David A., et al.
Publicado: (2023)

Childhood tonsillectomy alters the primary distribution of HPV‐related oropharyngeal squamous cell carcinoma
por: Altenhofen, Brannon, et al.
Publicado: (2020)

Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer
por: Farber, Nicholas J., et al.
Publicado: (2018)

Long-term Survival After Treating Cardiac Metastasis With Radiation and Immune Therapy: A Case Report
por: Arscott, W. Tristram, et al.
Publicado: (2018)

Impact of Label Restriction on Checkpoint-Inhibitor Use in Bladder Cancer and Changes in Mortality
por: Vader, Daniel T, et al.
Publicado: (2022)

Inverse Probability of Treatment Weighting and Confounder Missingness in Electronic Health Record-based Analyses: A Comparison of Approaches Using Plasmode Simulation
por: Vader, Daniel T., et al.
Publicado: (2023)

Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival
por: Fischer‐Valuck, Benjamin W., et al.
Publicado: (2018)

Intensity-modulated radiotherapy for prostate cancer
por: Fischer-Valuck, Ben W., et al.
Publicado: (2018)

Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE)
por: Chhatre, Sumedha, et al.
Publicado: (2015)

Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2022)

Reply to: Dose-escalation of radiation may improve outcomes of squamous cell carcinoma of bladder
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019)

Prostate-specific antigen-based screening: controversy and guidelines
por: Kim, Eric H, et al.
Publicado: (2015)

Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial
por: Chhatre, Sumedha, et al.
Publicado: (2023)

Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease Mapping
por: Zahrieh, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3rnioiqojjeh06l7918diecd29